Director/Assoc. Director of Targeted LNP Process Development

Director/Assoc. Director of Process Development About Kernal Biologics, Inc. Kernal Bio is a venture-backed therapeutics company engineering cells inside the body using AI-designed, selective mRNA and targeted LNP technology. By developing in vivo CAR-T therapies, Kernal Bio is advancing precision treatments for autoimmune diseases and blood cancers. The company was founded by experts from MIT, Harvard, Merck, and BMS, and its leadership team brings a track record of three FDA-approved therapies and over 120 patents. With support from leading investors, including Hummingbird Ventures, Amgen Ventures, Y Combinator, and HBM. Kernal Bio is transforming the future of cell therapy design and delivery. Job Summary: Kernal Bio is seeking a highly motivated and experienced Director/Associate Director of Targeted LNP Process Development with expertise in mRNA manufacturing to contribute to the development of its mRNA 2.0 platform for therapeutic applications. The successful candidate will inspire and lead a team responsible for the process development of mRNA-targeted LNP therapeutics. Proficiency in mRNA-tLNP chemistry, analytics, and biology workflows, coupled with experience in antibody-decorated lipid nanoparticle scale-up is essential for this role. Responsibilities: Lead the process development team and guide the company’s mRNA-tLNP process development. Work with senior management to expand the company’s CMC teamhttps://app3.greenhouse.io/plans/5733098003/ramp_up/skip Stay up-to-date on pertinent literature and prepare technical reports and white papers for internal use Oversee the synthesis, purification, and formulation of routine mRNA-tLNP products for preclinical studies Establish and optimize the company’s mRNA-tLNP manufacturing scale-up capability Help develop scalable strategies for mRNA-tLNP manufacturing Conduct mRNA-tLNP process development studies using the design of experiments (DOE) approach. Help with routine analytical and bioanalytical tasks such as HPLC, qPCR, ELISA, fragment analysis, cell-based assays, fluorescence, and flow cytometry. Coordinate in vivo studies in rodents for process quality validation Collaborate with the RD teams and support experiments on Kernal Bio’s RD pipeline Assist in IP filings and manuscript preparations Select and manage CROs and CDMOs (with some travel if/when needed). Finalize and transfer the process for IND enabling studies and GMP manufacturing campaigns Collaborate with academic partners for external preclinical studies Prepare CMC sections for regulatory filings Oversee the COGS reduction strategy for in vivo CAR-T product Present scientific findings internally and externally at critical scientific conferences and industry events Analyze, summarize, and present experimental results to team members and management Contribute to technical discussions intellectual property related to the development and application of Kernal’s proprietary technologies Explore new technologies and methods to optimize current processes in a fast-paced research environment Maintain up-to-date records and communicate results to team members in written technical reports and oral presentations Participate in experimental design and troubleshooting efforts Interpret, summarize experimental data and maintain excellent laboratory notebooks Requirements: PhD/MS/BS in Chemical Engineering, Biomedical Engineering, Chemistry, Biology, Molecular Biology, or a similar field 8 years of industry experience in CMC field with 5 years of academic or industry experience in nucleic acid and/or lipid nanoparticle manufacturing Attention to detail, ability to multi-task, and trouble-shoot Strong written and verbal communication skills Excellent record keeping and data management skills The ideal candidate is adaptable, enthusiastic about new challenges, has an innate curiosity, and a passion for learning Experience working in fast-paced startup environments Excellent organization ... (truncated, view full listing at source)